To test this hypothesis, we developed prostate (PC3) and colon (HT-29) cancer cell lines expressing iNOS under the control of a tetracycline-inducible promoter (PC3-pLIX_403-hNOS2 and HT-29-pLIX_403-hNOS2, respectively) [25]. Here, NOS2 is linked to cancer.